One‐Year Outcomes of Novel Transcatheter Edge‐to‐Edge Mitral Repair System in Patients With Functional Mitral Regurgitation
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70230 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Kai Xu und 21 weiteren Autor:innen. Beteiligte Einrichtung: General Hospital of Northern Theater Command, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Mitral Valve, Cardiac Catheterization, Heart Valve Prosthesis Implantation. Die Arbeit nennt 20 Literaturangaben. Gefördert von: This study was supported by the National Key Project of Research and Development Plan during the Fourteenth Five-Year Plan Period (2022YFC2503400), Major Scien….
Abstract (Originalsprache)
Background
Transcatheter edge‐to‐edge repair (TEER) improves outcomes in patients with heart failure and moderate‐to‐severe functional mitral regurgitation (FMR) who remain symptomatic despite the use of maximal doses of guideline‐directed medical therapy (GDMT). The SQ‐Kyrin‐M system is a novel TEER device designed for FMR treatment.
Aims
This multicenter, prospective, single‐arm study (ClinicalTrials.gov number: NCT05988450) evaluates the safety and efficacy of the SQ‐Kyrin‐M system in severe symptomatic FMR.
Methods
A total of 125 eligible patients (mean age 65.5 ± 8.1 years) with heart failure and moderate‐to‐severe or severe FMR who remained symptomatic despite the use of maximal doses of GDMT were involved in the analysis. The primary endpoint was the composite rate of all‐cause mortality and heart failure hospitalization at 1 year post‐intervention. Independent assessments were conducted by an echocardiography core laboratory (ECL) and a clinical events committee (CEC).
Results
At 1 year, the primary endpoint rate was 16.0% (20/125), and the composite major adverse event rate was 10.4%. Mitral regurgitation was reduced to ≤ 2+ in 94.2% of patients, with significant left ventricular reverse remodeling (LVEDV reduction: 33.8 ± 55.4 mL, p < 0.001). Patient‐reported outcomes improved significantly, with Kansas City Cardiomyopathy Questionnaire (KCCQ) scores increasing by 15.9 ± 18.8 points ( p < 0.001) and 6‐minute walk distance (6MWD) improving by 46.7 ± 90.7 m ( p < 0.001). The proportion of patients in New York Heart Association (NYHA) class I/II increased from 30.4% to 84.4% ( p < 0.001).
Conclusions
The SQ‐Kyrin‐M transcatheter mitral valve repair system bolsters the evidence supporting the safety and efficacy of TEER interventions for FMR patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
- Fuwai Yunnan Cardiovascular Hospital, Kunming, Yunnan, China.
- Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Nanjing First Hospital, Nanjing, Jiangsu, China.
- Shanghai Chest Hospital, Shanghai, China.
- Xiamen Cardiovascular Hospital Xiamen University, Fujian, Xiamen, China.
ORCID-Profile: Hong Jiang, Junjie Zhang, Xiang Cheng, Yingxian Sun, Bo Yu
Förderung
- This study was supported by the National Key Project of Research and Development Plan during the Fourteenth Five-Year Plan Period (2022YFC2503400), Major Scien…
Zitieren
APA
Xu, K., Zhu, D., Jiang, H., Chen, J., Chen, S., Zhang, J., He, B., Wang, Y., Fu, G., Chen, J., An, J., Xiu, J., Guo, X., Li, Y., Cheng, X., Li, P., Chen, Y., Zhou, S., Sun, Y., …, & Han, Y. (2025). One‐Year Outcomes of Novel Transcatheter Edge‐to‐Edge Mitral Repair System in Patients With Functional Mitral Regurgitation. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70230
Vancouver
Xu K, Zhu D, Jiang H, Chen J, Chen S, Zhang J, et al. One‐Year Outcomes of Novel Transcatheter Edge‐to‐Edge Mitral Repair System in Patients With Functional Mitral Regurgitation. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70230
BibTeX
@article{Xu2025,
author = {Xu, Kai and Zhu, Da and Jiang, Hong and Chen, Jing and Chen, Shaoliang and Zhang, Junjie and He, Ben and Wang, Yan and Fu, Guosheng and Chen, Jiyan and An, Jian and Xiu, Jiancheng and Guo, Xiaogang and Li, Yue and Cheng, Xiang and Li, Ping and Chen, Yuguo and Zhou, Shenghua and Sun, Yingxian and Yu, Bo and Pan, Xiangbin and Han, Yaling},
title = {One‐Year Outcomes of Novel Transcatheter Edge‐to‐Edge Mitral Repair System in Patients With Functional Mitral Regurgitation},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70230}
}
EUVIMED